HGF and benign prostatic hyperplasia: Yasuda et al. measured the concentration of active HGF (AHGF) in serum of patients with different grading of prostate cancer and benign prostate hyperplasia, and they found the concentration of HGF to be significantly higher in the cancer group (0.36 versus 0.28 ng/mL, resp).